Literature DB >> 19799493

HIV-infected adults from minority ethnic groups are willing to participate in research if asked.

Oluwatoyin Falusi Adeyemi1, Arthur T Evans, Mieoak Bahk.   

Abstract

HIV-infected ethnic minorities are underrepresented in HIV research. We sought to better understand the reasons for the low participation rates. An anonymous 1-page survey was administered to HIV-infected patients attending primary care clinics at the CORE Center in Chicago during 8 weeks in 2007. Four hundred seventeen HIV-infected patients (mean age, 43 years; 60% male, 65% African American, 21% Hispanic) completed the survey. Forty percent had previously participated in research but only 29% had ever been asked by their primary care provider (PCP) to participate. The strongest predictor of participation was being asked (RR 3.0; p < 0.001). The majority of patients would agree (65%) or consider (30%) participating in a study if recommended by their PCP. Being treated like a "guinea pig" was the most common (40%) concern of patients. However, despite this concern, patients would still agree to participate if recommended by their PCP. In our urban cohort of HIV-infected patients, the majority were willing to participate in HIV research studies if asked, highlighting the important role of primary providers in improving research participation.

Entities:  

Mesh:

Year:  2009        PMID: 19799493     DOI: 10.1089/apc.2009.0008

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  10 in total

1.  Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.

Authors:  Thomas P Giordano; Glenn Bartsch; Yafeng Zhang; Ellen Tedaldi; Judith Absalon; Sharon Mannheimer; Avis Thomas; Rodger D MacArthur
Journal:  AIDS Patient Care STDS       Date:  2010-05       Impact factor: 5.078

Review 2.  A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders.

Authors:  Sheba George; Nelida Duran; Keith Norris
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

3.  Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials.

Authors:  Marya Viorst Gwadz; Pablo Colon; Amanda S Ritchie; Noelle R Leonard; Charles M Cleland; Marion Riedel; DeShannon Bowens; Angela D Banfield; Patricia Chang; Robert Quiles; Donna Mildvan
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

4.  Impact of Race Versus Education and Race Versus Income on Patients' Motivation to Participate in Clinical Trials.

Authors:  Anita Kurt; Hope Kincaid; Lauren Semler; Jeanne L Jacoby; Melanie B Johnson; Beth A Careyva; Brian Stello; Timothy Friel; John C Smulian; Mark C Knouse
Journal:  J Racial Ethn Health Disparities       Date:  2017-12-26

5.  Predictors of screening for AIDS clinical trials among African-Americans and Latino/Hispanics enrolled in an efficacious peer-driven intervention: uncovering socio-demographic, health, and substance use-related factors that promote or impede screening.

Authors:  Marya Gwadz; Charles M Cleland; Noelle R Leonard; Amanda S Ritchie; Angela Banfield; Marion Riedel; Pablo Colon; Donna Mildvan
Journal:  AIDS Behav       Date:  2013-02

6.  Beliefs about participating in research among a sample of minority persons living with HIV/AIDS in New York City.

Authors:  Tiffany Floyd; Shilpa Patel; Elisa Weiss; Soye Zaid-Muhammad; David Lounsbury; Bruce Rapkin
Journal:  AIDS Patient Care STDS       Date:  2010-06       Impact factor: 5.078

7.  Racial/ethnic differences in trust in health care: HIV conspiracy beliefs and vaccine research participation.

Authors:  Ryan P Westergaard; Mary Catherine Beach; Somnath Saha; Elizabeth A Jacobs
Journal:  J Gen Intern Med       Date:  2014-01       Impact factor: 5.128

8.  Recruitment and ethical considerations in HIV cure trials requiring treatment interruption.

Authors:  Michael P Arnold; David Evans; Nelson Vergel
Journal:  J Virus Erad       Date:  2015-01-01

9.  Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.

Authors:  M Keith Rawlings; Emilio Letang; Romina Quercia; Richard Grove; Ralph DeMasi; Sherene Min; Vani Vannappagari; Andrew Zolopa; Jean van Wyk; Kimberly Smith
Journal:  Open Forum Infect Dis       Date:  2022-06-24       Impact factor: 4.423

10.  'What do I know? Should I participate?' Considerations on participation in HIV related research among HIV infected adults in Bangalore, South India.

Authors:  Rashmi J Rodrigues; Jimmy Antony; Shubha Krishnamurthy; Anita Shet; Ayesha De Costa
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.